Search - tctmd.com

Displaying 541 - 560 of 1511

Sort: Relevancy | Date

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Inspiron

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Micell

Presenter: Alexandre Abizaid, Ashok Seth, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Firehawk

Presenter: Alexandre Abizaid, Ashok Seth, Runlin Gao

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Desyne BD

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers

Presenter: Nicolas Foin, Giampaolo Niccoli

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Biomime

Presenter: Alexandre Abizaid, Ashok Seth

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Alex

Presenter: Alexandre Abizaid, Ashok Seth, Dariusz Dudek

October 31, 2016

Presentation TCT 2016

Device and Clinical Program Highlights: Abluminus

Presenter: Alexandre Abizaid, Ashok Seth, Dinesh Shah

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES!

Presenter: Stephan Windecker, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Presenter: Stephan Windecker, Michael Joner

October 31, 2016

Presentation TCT 2016

Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences?

Presenter: Stephan Windecker, Julinda Mehilli

October 31, 2016

Presentation TCT 2016

Potential Advantages and Pitfalls of Bioabsorbable Polymers

Presenter: Stephan Windecker, Renu Virmani

October 31, 2016

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla

October 30, 2016

Presentation TCT 2016

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman

October 30, 2016

Advertisement

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

Device Specifications and Clinical Program Update: Inspiron

Device Specifications and Clinical Program Update: Micell

Device Specifications and Clinical Program Update: Firehawk

Device Specifications and Clinical Program Update: Desyne BD

TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Device Specifications and Clinical Program Update: Biomime

Device Specifications and Clinical Program Update: Alex

Device and Clinical Program Highlights: Abluminus

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES!

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences?

Potential Advantages and Pitfalls of Bioabsorbable Polymers

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content